Top 20 Japanese Companies & Their Pipelines 2009

Countries covered: Japan In spite of the global economic downturn, Japanese pharmaceutical companies are realizing growth by capitalizing on M&A opportunities, predominantly through acquisition of specialty and generic pharmaceutical companies based in the United States and Asia-Pacific region. In addition to expansion through acquisition strategies, Japanese pharmaceutical manufacturers may realize opportunities closer to home, as the Asia-Pacific region is a major emerging market for the development of orphan drugs. Many leading Asian countries have a legal framework for the development of novel medicines, and the market for the region is expected to notice significant growth. In fact, Japan's more than $60+ billion pharmaceutical market value is expected to top $100 billion by 2020. In this report, readers can access statistical data and analytical reviews of the top companies based in the country, identify the top therapeutic areas in terms of growth percentage for the region, gain insight into the M&A activity and future business strategy of Japanese companies growing their global presence, and track potential competitive products as Japanese companies look to expand into new markets.

Additional Information

The following information is included for the top 20 Japanese companies, which were determined based on their healthcare revenue generated during 2008:

• Each pipeline products’ chemical or substance composition, intended indication, clinical status, region of development, and developer/marketer
• Pipeline status details preclinical development, Phase I, Phase II, Phase III, and awaiting approval
• Region of development includes the U.S., Europe, and Japan
• Select 2008 and 2007 financial data such as revenue, net income, earnings per share, and R&D expenditure

The report overview includes news updates and overall status for the leading Japanese companies. The analysis details promising pipeline candidates, the R&D structure of each corporation, as well company management plans and goals.

More Japan Prescription Drugs Reports

Japan Pharma Market Intelligence by PharmaIntellect
Looking at the great deal of business interest in the Japan Pharmaceutical space, we have recently published a report - "Japan Pharma – Market ...

Japan Pharmaceuticals and Healthcare Report Q2 2012 by Business Monitor International


The Pharmaceutical Market: Japan (pdf/xls) by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...

Japan Pharmaceutical Industry & Forecast-Focus on OTC and Prescription Drugs Market by AM Mindpower Solutions
EXECUTIVE SUMMARY The present report entitled "Japan Pharmaceutical Industry & Forecast-Focus on OTC and Prescription Drugs Market", discuss market size (historical, present and future) ...

Abilify - Analysis and Estimates from 2002 to 2020 by GlobalData
Abilify - Analysis and Estimates from 2002 to 2020 Summary GlobalData’s pharmaceuticals report, “Abilify - Analysis and Estimates from 2002 to 2020” provides Abilify sales estimates ...

See all reports like this >>

More Japan Reports

D&B Country Report: Japan by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Plimsoll Portfolio Analysis - Guard Services (Japan) by Plimsoll Publishing Ltd.
The Plimsoll Portfolio Analysis - Guard Services is a comprehensive evaluation of the Japanese market. The revised and updated 2008 edition analyses the financial performance ...

Plimsoll Portfolio Analysis - Business Consultants (Japan) by Plimsoll Publishing Ltd.
The Plimsoll Portfolio Analysis - Business Consultants is a comprehensive evaluation of the Japanese market. The revised and updated 2008 edition analyses the financial performance ...

Plimsoll Portfolio Analysis - Land Developers (Japan) by Plimsoll Publishing Ltd.
The Plimsoll Portfolio Analysis - Land Developers is a comprehensive evaluation of the Japanese market. The revised and updated 2008 edition analyses the financial performance ...

Japan: Country Profile by MarketLine
INTRODUCTION This report provides a detailed analysis of Japan, providing an overview of its political, economic and business environment, represented both textually and in graph and ...

See all reports like this >>